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Objectives. To determine the effects of various monomers on conversion and cytocompati-
bility of dental composites and to improve these properties without detrimentally affecting
mechanical properties, depth of cure and shrinkage.
Methods. Composites containing urethane dimethacrylate (UDMA) or bisphenol A glycidyl
methacrylate (Bis-GMA)with poly(propylene glycol) dimethacrylate (PPGDMA) or triethylene
glycol dimethacrylate (TEGDMA)were characterized using the following techniques: conver-
sion (FTIR at 1 and 4mm depths), depth of cure (BS EN ISO 4049:2009 and FTIR), shrinkage
(BS EN ISO 17304:2013 and FTIR), strength and modulus (biaxial ﬂexural test) and water
sorption. Cytocompatibility of composites and their liquid phase components was assessed
using three assays (resazurin, WST-8 and MTS).
Results. UDMA signiﬁcantly improved conversion, BFS and depth of cure compared to Bis-
GMA, without increasing shrinkage. UDMA was cytotoxic at lower concentrations thanDegree of conversion
Polymerization shrinkage
PPGDMA
TEGDMA
UDMA
Bis-GMA
Bis-GMA, but extracts of Bis-GMA-containing composites were less cytocompatible than
of those containing UDMA. PPGDMA improved conversion and depth of cure compared to
TEGDMA,without detrimentally affecting shrinkage. TEGDMAwas shown by all assays to be
highly toxic. Resazurin, but notWST-8 andMTS, suggested that PPGDMAexhibited improved
cytocompatibility compared to TEGDMA.
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Signiﬁcance. The use of UDMA and PPGDMA results in composites with excellent conversion,
depth of cure and mechanical properties, without increasing shrinkage. Composites con-
taining UDMA appear to be slightly more cytocompatible than those containing Bis-GMA.
These monomers may therefore improve the material properties of dental restorations, par-
ticularly bulk ﬁll materials. The effect of diluent monomer on cytocompatibility requires
further investigation.
©  2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
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ental composites are widely used as dental restorative mate-
ials for their high strength and excellent aesthetics. These
onsist primarily of: a liquid phase containing monomers and
n initiator system (typically photo-activated); a ﬁller phase
typically boro-aluminosilicate glass particles), which pro-
ides optimal mechanical and aesthetic properties; and silane,
 coupling agent which enables bonding of the polymer to the
ller. Bisphenol A glycidyl methacrylate (Bis-GMA), urethane
imethacrylate (UDMA) and triethylene glycol dimethacrylate
TEGDMA) are some of the most commonly used monomers
n dental composites. Upon photoinitiation, they form a cross-
inked polymer network which hardens and entraps the ﬁllers
1].
Composites are typically layered in increments and this is
ime-consuming for clinicians, since it requires curing each
ncrement before proceeding with the next. This is partic-
larly an issue in deeper posterior cavities, in which many
ncrements may be required. As a result, bulk ﬁll materials
im to overcome this issue by utilizing photoinitiators which
re effective at depths of 4–5 mm,  as well as monomers with
ow double bond concentration and, in some cases, monomers
hich are cleaved during polymerization.
One of the major limiting factors of composites is the
lose interplay between degree of conversion and other char-
cteristics, including mechanical properties, polymerization
hrinkage, water sorption and elution of toxic components.
ince the level of residual monomer in a composite affects
ts biocompatibility, mechanical properties and aesthetics [2],
igh conversion is ideal for optimization of these properties.
onversely, however, high conversion is typically associated
ith high volumetric shrinkage. In the patient, this can result
n microbial microleakage (penetration of pathogens between
he composite and tooth), recurrent caries and, ultimately,
ailure of the restoration. Monomers with low double bond
oncentration and subsequent low shrinkage are therefore
ptimal, particularly in the case of bulk ﬁll materials, due to
he larger volume of each increment.
The aim of the present research was to improve the con-
ersion, strength and cytocompatibility of dental composites
ithout detrimentally affecting polymerization shrinkage or
epth of cure by fully replacing Bis-GMA with UDMA and
EGDMA with PPGDMA. This is due to the greater ﬂexibility
nd cross-linking density of UDMA than Bis-GMA [3,4] and the
reater ﬂexibility and signiﬁcantly lower double bond concen-
ration of PPGDMA than TEGDMA. In order to investigate the
ffect of each monomer on cytocompatibility, human gingivalBY  license (http://creativecommons.org/licenses/by/4.0/).
ﬁbroblasts (HGF) were cultured in solutions of each individual
liquid phase component at varying concentrations, as well as
in extracts of each composite formulation. Due  to the variabil-
ity between different cell viability assays, which arises from
the targeting of different enzymes within the cell, and the
ambiguity of the widely used term ‘biocompatibility’ [5], three
assays were compared. The null hypothesis was that replace-
ment of Bis-GMA with UDMA and TEGDMA with PPGDMA
would have no effect on these properties.
2.  Materials  and  methods
2.1.  Materials
2.1.1.  Composite  paste  preparation
Microhybrid dental composites [1] were prepared using
10 wt% 40 nm fumed silica (Aerosil OX-50, Evonik Indus-
tries AG, Essen, Germany) and 90 wt% silane-treated bar-
ium boro-aluminosilicate glass particles of various sizes
(DMG Chemisch-Pharmazeutische Fabrik GmbH, Hamburg,
Germany). These were combined with four dimethacrylate-
based liquid phases. The liquid phases consisted of bulk
monomer UDMA (DMG) or Bis-GMA (Polysciences Inc., Eppel-
heim, Germany) combined with diluent monomer PPGDMA
(Polysciences) or TEGDMA (DMG). The bulk to diluent molar
ratio was 3.5:1. The liquid phases also contained 40 mM
(0.58–0.61 wt%) photoinitiator camphorquinone (CQ, DMG),
60 mM (0.82–0.86 wt%) co-initiator N,N-dimethylaminoethyl
methacrylate (DMAEMA, Sigma–Aldrich, Gillingham, UK) and
100 ppm inhibitor butylated hydroxytoluene (Sigma–Aldrich).
The two phases were combined to form composite pastes
using a centrifugal planetary mixer (SpeedMixer, Hauschild
Engineering, Hamm,  Germany), in order to minimize air incor-
poration and ensure complete wetting of ﬁller particles. The
powder to liquid ratio (PLR) was kept constant at 40 vol% liq-
uid (19.3–20.3 wt%, depending on liquid phase density). Dental
composites were designated abbreviations based on their bulk
and diluent monomer content: UP, UT, BP and BT, where U, B,
P and T represent UDMA, Bis-GMA, PPGDMA and TEGDMA,
respectively. Commercial composite Filtek Z250 (3M ESPE, St.
Paul, MN, USA) was used for comparison.
2.1.2.  Disc  specimen  production
Except where otherwise stated, disc-shaped specimens were
moulded by applying composite pastes to metal circlips
(internal diameter 10.2 mm,  thickness 1 mm)  and pressing
them between two sheets of acetate. This prevents oxygen
inhibition during polymerization and expels excess paste,
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ensuring similar specimen thickness. Specimens were photo-
polymerized using a blue light emitting diode curing unit with
a wavelength of 450–470 nm and power output with periodic
level shifting of 1100–1330 mW/cm2 (Demi Plus, Kerr Dental,
Orange, CA, USA), in direct contact with the acetate. The cur-
ing duration for each testing method varied and is detailed in
each corresponding section.
2.2.  Methods
2.2.1.  Handling  properties  and  wet-point  determination
The wet-point of each liquid was determined by gradually
adding a small quantity of liquid phase to a known mass of
ﬁller phase and mixing, until the ﬁller was sufﬁciently wetted
and a cohesive paste had been formed. The quantity of liquid
phase added was recorded and notes were made regarding
the handling properties of each formulation. The wet-point
(vol%) was then calculated from the total mass of liquid and
the density of each component.
2.2.2.  Polymerization  properties
2.2.2.1.  Degree  of  conversion.  The conversion of each com-
posite was determined using Fourier transform infrared
spectroscopy (FTIR, System 2000, PerkinElmer, Seer Green,
UK). Composite paste was applied to either a single or four
stacked circlips of the same dimensions. These were placed
on the diamond of an attenuated total reﬂectance acces-
sory (Golden Gate ATR, Specac Ltd., Orpington, UK) and
covered with a sheet of acetate. After an initial spectrum
of the uncured composite had been obtained, spectra were
recorded continuously for 1000 s (n = 3). The specimens were
photo-polymerized from the top for the ﬁrst 20 s. Spectra
were recorded at a wavelength range of 800–1800 cm−1 and
resolution of 8 cm−1. Absorbance proﬁles were obtained at
1319 ± 1 cm−1 (C–O stretch bond) and 1334 ± 2 cm−1 (baseline)
and used to calculate conversion at 1 mm and 4 mm depths
using Eq. (1):
C =
[
1 −
(
Af
Ao
)]
× 100 (1)
where C is conversion. Af and A0 are ﬁnal and initial
absorbance above baseline, respectively [6].
2.2.2.2.  Polymerization  shrinkage.
2.2.2.2.1.  Shrinkage  based  on  conversion.  The volumetric
shrinkage of composites was calculated from the conversion
data using Eq. (2) [7], which is based on the ﬁnding that
methacrylate esters typically undergo volumetric shrinkage
of s = 22.5 cm3/mol upon polymerization [8,9]:
S = 100 ×
(
smC
∑
i
(
nixi
Wi
))
(2)
where S, m, C, , ˙, i, n, x and W are shrinkage (vol%), monomer
mass fraction within composite, conversion, composite den-
sity, sum of all monomers in liquid phase, each monomer
in liquid phase, number of C C bonds per molecule, mass
fraction of monomer in liquid phase and molecular mass,
respectively.2 ( 2 0 1 6 ) 264–277
2.2.2.2.2.  Shrinkage  based  on  volume  change.  The shrink-
age of composites was also obtained by measuring the density
of polymerized and unpolymerized specimens according to BS
EN ISO 17304:2013 [10]. This technique uses an analytical bal-
ance equipped with a density determination apparatus (AG
204 & MS-DNY-43, Mettler Toledo, Beaumont Leys, UK) and is
based on Archimedes’ principle. Disc specimens were cured
for 40 s from each side to ensure complete conversion. Speci-
men  edges were polished to remove loose chips. The mass of
three cured and three uncured specimens of each formulation
were measured in air and under deionized water. Each value
for mass under water was averaged from 10 readings. The
shrinkage of composites and their SD were calculated using
the equations provided in the standard.
2.2.2.3.  Depth  of  cure.  The depth of cure of composites (n = 3)
was measured according to BS EN ISO 4049:2009 [11]. Brieﬂy,
composite paste was applied to a brass split-mould (internal
diameter 4 mm,  height 6 mm)  and photo-polymerized for 20 s
from the top. The specimen was removed from the mould and
a plastic spatula was used to remove any uncured material
from the bottom. The depth of cured material was measured
using digital callipers to an accuracy of ±0.01 mm  and the
reading was halved, as required by the standard, in order to
give a value for depth of cure.
2.2.2.4.  Water  sorption.  In order to determine water sorption,
disc specimens were cured for 40 s from each side to ensure
maximum conversion. The mass of composites before and
after immersion in 10 mL deionized water for one week was
then determined using an analytical balance.
2.2.3.  Mechanical  properties
Composite disc specimens (n = 10) were cured for 40 s from
each side. Specimens were stored dry for 24 h, before place-
ment in 10 mL  deionized water at 37 ◦C for one week. They
were then tested using a biaxial ﬂexural test (Autograph AGS-
X, Shimadzu, Milton Keynes, UK), with a 2 kN load cell and
ball-on-ring jig at a cross-head speed of 1 mm/min, until spec-
imen failure. Biaxial ﬂexural strength (BFS, MPa)  and modulus
of tensile elasticity (E, GPa) were calculated using Eqs. (3) and
(4), respectively,
BFS = P
t2
[
(1 + v)
(
0.485 ln
(
a
t
)
+ 0.52
)
+ 0.48
]
(3)
E =
(
P
wc
)
×
(
ˇca2
t3
)
(4)
where BFS, P, t,  and a are biaxial ﬂexural strength, failure
load (N), specimen thickness (mm),  Poisson’s ratio (0.3) and jig
support radius (4 mm),  respectively, and E, (P/Wc) and ˇc
are modulus, gradient of elastic region and center deﬂection
function (0.5024) [12], respectively.
2.2.4.  Cytocompatibility
2.2.4.1.  Cell  culture.  Primary HGF were obtained from a com-
mercial source (ScienCell Research Laboratories, Carlsbad,
CA, USA). HGF were cultured under standard conditions
(37 ◦C, 95% air, 5% CO2, 95% relative humidity) in Dulbecco’s
3 2 ( 2 0 1 6 ) 264–277 267
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Table 1 – Cytocompatibility assay parameters.
Substrate Incubation
time (min)
Measurement
Resazurin, 10% 90 Fluorescence – excitation:
560 nm, emission: 590 nm
WST-8, 10% 80 Absorbance – 460 nmd e n t a l m a t e r i a l s 
odiﬁed Eagle medium (DMEM, Gibco, Life Technologies, Pais-
ey, UK) supplemented with 10% foetal bovine serum (Gibco)
nd 1% penicillin/streptomycin (PAA Laboratories, GE Health-
are, Chalfont St. Giles, UK). Passage numbers 4–8 were used
or cytocompatibility studies.
.2.4.2.  Preparation  of  test  solutions.  Test solutions were pre-
ared in serum-free DMEM.  As is typical in biomaterials
esting, serum-free medium was used in order to prevent
dsorption of serum proteins to material components. Con-
rols consisted of serum-free DMEM.
2.2.4.2.1.  Liquid  phase  components.  Five ten-fold serial
ilutions of each component were prepared in serum-free
MEM,  ranging from 0.01 to 100 mM for DMAEMA, UDMA,
PGDMA and TEGDMA, and 0.001 to 10 mM for CQ and Bis-
MA, due to their lower solubility. The solutions were stored
or ∼30 min  at 60 ◦C and then stirred using a sterile spatula,
n order to aid dissolution of components with low solubility,
articularly the bulk monomers.
2.2.4.2.2.  Composite  extracts.  In order to prepare speci-
ens for extract testing, a 1 mm thick circlip atop a sheet of
cetate was ﬁlled with composite and covered with acetate.
 further three circlips were stacked on top and ﬁlled with
omposite and covered with acetate. The resultant 4 mm deep
tack was then photo-polymerized for 20 s from the top. The
ottom 1 mm thick section was removed from the mould and
ncubated in 650 L serum-free DMEM at 37 ◦C. This provided
n extraction ratio of 1 mL/3 cm2 surface area, as required
y ISO 10993-12:2009 [13]. Specimens (n = 3) were agitated at
00 rpm during extraction (orbital shaker, Stuart Scientiﬁc,
tone, UK). After 24 h, specimens were transferred to fresh
edium and incubated for a further 6 days, yielding extracts
rom 1 and 7-day time-points.
.2.4.3.  Cytocompatibility  assays.  HGF were seeded at a den-
ity of 30,000 cells/cm2 in 96 well plates (n = 3 per specimen,
ime-point and assay). After an initial 24 h seeding period, cell
ulture medium was replaced with 100 L of the specimen
component solution, composite extract or control). The solu-
ions were thoroughly mixed using a vortex mixer (Stuart SA8,
ibby Scientiﬁc, Stone, UK) in order to ensure even dispersion
f dissolved components. Cytocompatibility was assessed
fter a further 24 h of culture (48 h time-point), in accor-
ance with ISO 10993-5:2012 [14]. The specimen was then
eplaced with serum-free DMEM and cultured for a further
4 h recovery period (72 h time-point). Three water-soluble
ell metabolic activity assays were used to assess cytocom-
atibility: resazurin (alamarBlue Cell Proliferation Assay,
dB Serotech, Bio-Rad Laboratories Inc., Hemel Hempstead,
K); water-soluble tetrazolium salt-8 (WST-8, Cell Counting
it-8, Sigma–Aldrich); and 3-(4,5-dimethylthiazol-2-yl)-5-(3-
arboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
alt (MTS, CellTiter 96 AQueous One Solution Cell Proliferation
ssay, Promega, Southampton, UK). Medium was aspirated
rom the cells and replaced with 100 L cell culture medium
ontaining the corresponding substrate (Table 1). After incu-
ation at 37 ◦C, ﬂuorescence (FLx800, BioTek, Potton, UK) or
bsorbance (Inﬁnite M200, Tecan, Männedorf, Switzerland)
as measured. Standard curves were obtained by seeding a(reference: 650 nm)
MTS, 20% 60 Absorbance – 490 nm
(reference: 630 nm)
range of cell concentrations in 96 well plates, 2 h prior to each
assay.
2.2.5.  Statistical  analyses
One-way analysis of variance (ANOVA) and post-hoc Tukey’s
tests were used to determine signiﬁcance (p ≤ 0.05) between
composite formulations (UP, UT, BP, BT and Z250). Two-way
ANOVA and post-hoc Tukey’s tests were also used in order
to determine the signiﬁcance of the effects of multiple fac-
tors, e.g. UDMA vs. Bis-GMA and PPGDMA vs. TEGDMA. For all
techniques, the standard deviation (SD) of each formulation
was displayed on graphs, except in the case of polymerization
shrinkage, where the SD was averaged for each technique, due
to the high variability of the volume change method. Statis-
tical signiﬁcance is presented on graphs (*p < 0.05, **p < 0.01,
***p < 0.005 or ****p < 0.001).
3.  Results
3.1.  Handling  properties  and  wet-point
All experimental formulations had wet-points of
33.3 ± 0.4 vol% liquid. At this level, formulation pastes
containing Bis-GMA felt considerably less malleable during
specimen moulding than those produced with UDMA. At
40 vol% liquid, all formulations were slightly more  malleable,
but formulations containing Bis-GMA still exhibited lower
malleability than those containing UDMA. Z250 had handling
properties between those of Bis-GMA- and UDMA-containing
composites. No discernible difference in handling properties
was observed between PPGDMA and TEGDMA.
3.2.  Polymerization  properties
3.2.1.  Conversion
Experimental composites containing UDMA had, on average,
1.2 and 1.3 times higher conversion at 1 and 4 mm depth,
respectively, than those containing Bis-GMA (average p-value
of both depths = 0.001) (Fig. 1a). Replacement of TEGDMA with
PPGDMA further increased conversion by 1.1 and 1.2 times at 1
and 4 mm,  respectively (average p-value of both depths < 0.01).
UP had the highest conversion (68% and 65% at 1 and 4 mm).  At
both depths, UP’s high conversion was highly statistically sig-
niﬁcant compared to BP, BT and Z250 (p < 0.001) and at 1 mm,
it was signiﬁcantly higher than that of UT (p < 0.05). Z250 had
the lowest (50% and 39% at 1 and 4 mm)  and was compara-
ble to BT. Composites containing Bis-GMA (BP, BT and Z250),
showed a signiﬁcant reduction in conversion upon increasing
depth from 1 to 4 mm.
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Fig. 1 – (a) Conversion of composites at 1 and 4 mm depth. Columns represent mean, error bars represent SD. (b) Shrinkage
of 1 mm thick composite discs, calculated from conversion or volume change. Columns represent mean, error bars represent
mean SD of the corresponding technique (±0.05 and ±0.23 vol% for conversion and volume change, respectively). (c) Depth
of cure of composites. (d) Water sorption of composites after immersion in deionized water for one week. (c, d) Crosses
represent mean, boxes represent 25–75 percentiles, error bars represent SD.3.2.2.  Shrinkage
Based on conversion at 1 mm depth, the shrinkage of UDMA-
containing composites was predicted to be 1.2 times higher, on
average, than those containing Bis-GMA (p < 2 × 10−5) (Fig. 1b).
Composites containing TEGDMA were estimated to have
1.1 times higher shrinkage than those containing PPGDMA
(p < 0.04). When shrinkage was determined by volume change,
however, no statistically signiﬁcant effect of monomer could
be observed. This was due to the high standard deviation of thetechnique. The shrinkage of Z250 could not be calculated using
conversion data, since its exact composition was unknown.
The measured shrinkage, however, of Z250 was comparable to
all experimental formulations.3.2.3.  Depth  of  cure
The depth of cure (Fig. 1c) was highly comparable for all com-
posites (2.7 ± 0.25 mm),  regardless of monomer composition
(F = 0.96).
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.2.4.  Water  sorption
he water sorption of formulations containing TEGDMA was,
n average, 1.2 times higher than that of those containing
PGDMA (p < 0.02) (Fig. 1d). On average, UDMA induced ∼1.1
imes higher water sorption than Bis-GMA, although this was
ot statistically signiﬁcant. Z250 had the lowest water sorp-
ion, comparable to that of BP. UT had the highest water sorp-
ion, signiﬁcantly higher than that of BP and Z250 (p < 0.05).
.3.  Mechanical  propertiesxperimental composites containing UDMA had signiﬁcantly
igher strength (153–158 MPa)  than those containing Bis-GMA
ig. 2 – (a) Biaxial ﬂexural strength and (b) modulus of
ensile elasticity of composites after storage in deionized
ater at 37 ◦C for one week. Crosses represent mean, boxes
epresent 25–75 percentiles, error bars represent SD.( 2 0 1 6 ) 264–277 269
(p = 1 × 10−7). The strength of BP was signiﬁcantly higher than
that of BT (127 and 99 MPa,  respectively; p < 0.05) (Fig. 2a). The
modulus of experimental formulations containing PPGDMA
was, on average, slightly lower than that of formulations con-
taining TEGDMA (6.15 and 6.75 GPa, respectively; p = 0.009)
(Fig. 2b). Z250 had the highest strength (173 MPa)  and lowest
modulus (5.3 GPa).
3.4.  Cytocompatibility
3.4.1.  Comparison  of  resazurin,  WST-8  and  MTS  assays
The apparent cell density of HGF after 48 and 72 h culture in
serum-free DMEM is shown in Fig. 3. Resazurin and WST-8
assays reported a similar increase in apparent cell density
from 30,000 to ∼49,000 cells/cm2 between 0 and 48 h. MTS
reported a lesser increase in apparent cell density (from
30,000 to 37,000 cells/cm2 after 48 h). After 72 h in culture,
the resazurin assay reported cell density to have increased
to 113,000 cells/cm2, whereas the WST-8  assay reported cell
density to be 74,000 cells/cm2. MTS  again reported only a
small increase in apparent cell density (45,000 cells/cm2).
Since the assays reported different cell densities in the
controls at different time-points, subsequent data are nor-
malized to the control for the corresponding assay and
time-point and are reported in terms of relative metabolic
activity.
3.4.2.  Composite  component  cytocompatibility
The relative metabolic activity of surviving HGF following
exposure to serial dilutions of liquid phase components, as
well as following a subsequent recovery period, is presented
in Fig. 4. The dashed lines represent the mean value obtained
for the DMEM control for each corresponding time-point
and assay. All components caused a typical, concentration-
dependent reduction in cell number as concentration was
Fig. 3 – Initial seeding density of HGF determined by cell
counting (0 h, cross), and apparent density after culture in
DMEM for 48 h (unﬁlled symbols) and 72 h (ﬁlled symbols),
as assessed by resazurin (circle), WST-8  (triangle) and MTS
(square) assays. Error bars represent SD.
270  d e n t a l m a t e r i a l s 3 2 ( 2 0 1 6 ) 264–277
Fig. 4 – Metabolic activity (relative to the corresponding control) of surviving HGF after culture in aqueous solutions of
composite liquid phase components (a) CQ, (b) DMAEMA, (c) UDMA, (d) Bis-GMA, (e) PPGDMA or (f) TEGDMA. Resazurin
(circle), WST-8  (triangle) and MTS  (square) assays were  performed after 24 h culture in the solutions (48 h time-point,
unﬁlled symbols), and after a subsequent 24 h recovery period in DMEM (72 h time-point, ﬁlled symbols). Component
concentrations ranged from 0.001 to 10 mM (a and d) or 0.01 to 100 mM (b, c, e and f). Dashed lines represent the mean value
of the control, error bars represent SD.
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ncreased, though the extent of this relationship depended
n the assay. In the case of all components, a concentration
f 10 mM was sufﬁcient to cause close to 100% reduction in
etabolic activity.
After 48 h, WST-8  indicated a direct correlation between CQ
oncentration (Fig. 4a) and metabolic activity, with 0.001 and
.01 mM having no signiﬁcant effect on metabolic activity. As
oncentration was increased to 0.1, 1 and 10 mM,  metabolic
ctivity was reduced by 17, 33 and 98%, respectively. Resazurin
eported similar levels (±5%) of metabolic activity at most con-
entrations, whereas MTS  values were up to 15% higher. After
2 h, resazurin reported similar levels of relative metabolic
ctivity to after 48 h. WST-8, however, indicated similar levels
f metabolic activity to the control (±7%) at all concentrations
xcept ≥10 mM,  at which cells did not recover. MTS showed
levated metabolic activity (10–38% greater than that of the
ontrol) at all concentrations after 72 h, except ≥10 mM.
By contrast, at 48 h, 0.01 mM DMAEMA (Fig. 4b) caused an
6–95% reduction in metabolic activity in all assays, with no
ecovery after 72 h. All assays indicated that concentrations
0.1 mM caused total inhibition of metabolic activity. Simi-
arly, at a critical concentration of 0.01 mM or higher, UDMA
Fig. 4c) and TEGDMA (Fig. 4f) both inhibited metabolic activity
n all assays.
Bis-GMA (Fig. 4d) appeared to be more  cytocompatible
han DMAEMA, UDMA and TEGDMA. After 48 h, WST-8  indi-
ated that concentrations of 0.001–0.01 mM had no effect on
etabolic activity. It fell, however, by 7 and 66% upon increas-
ng concentration to 0.1 and 1 mM,  respectively. The other
ssays showed a similar trend, but at 0.001–0.1 mM the values
eported by resazurin and MTS  were ∼10–15% and ∼23–28%
ower, respectively. After 72 h, values obtained by WST-8  assay
ere elevated by between 7 and 20% compared to the previ-
us time-point, except at 10 mM.  At 0.001–0.1 mM,  metabolic
ctivity appeared higher than the controls. Resazurin reported
imilar values (±10%) after 72–48 h.
HGF exposed to PPGDMA (Fig. 4e) exhibited more  com-
lex trends. The three assays gave different results for
oncentration-dependent effects on relative metabolic activ-
ty. According to all assays, at ≥10 mM,  PPGDMA completely
nhibited metabolic activity after 48 h and this did not
ecover after 72 h. Upon lowering concentration, there was a
mall increase in activity according to the WST-8  and MTS
ssays, but it remained well below control values and was
ot enhanced by providing additional recovery time. Con-
ersely, at 48 h and PPGDMA level below 0.1 mM,  the cell
ctivity according to the Resazurin test tended to higher val-
es than with the control. By 72 h, however, this “excess”
etabolic activity was down to control levels. Concentra-
ions of 0.01, 0.1 and 1 mM,  PPGDMA caused a reduction in
ST-8 activity of 76, 85 and 92%, respectively, after 48 h.
hese levels remained unchanged after 72 h. MTS showed
imilar values to WST-8. By contrast, after 48 h, resazurin
ctivity was elevated by 63 and 35% above the control at
.01 and 0.1 mM,  respectively, and at 1 mM was similar to
he control. After 72 h, these values fell, with resazurin
ctivity remaining 12% above the control at 0.01 mM,  and
eing 7 and 80% lower than the control at 0.1 and 1 mM,
espectively.( 2 0 1 6 ) 264–277 271
3.4.3.  Composite  extract  cytocompatibility
The metabolic activity of HGF after culture in composite
extracts is presented in Fig. 5. Signiﬁcant differences were
again observed between different assays. In order to facilitate
elucidation of trends, data are expressed as a percentage of
the control for each corresponding extract (1 or 7 days) and
assay time-point (48 or 72 h).
After 24 h exposure to 1 day composite extracts (48 h time-
point), a general downward trend in resazurin metabolism
was observed as follows: UP > UT ≥ BP > BT ≥ Z250. Although
WST-8 activity differed slightly (UP ≈ UT > BP ≈ BT > Z250), both
assays conﬁrmed that the extracts from the lower quadrant
of 4 mm deep composite samples containing UDMA had less
effect on the 48 h metabolic activity than those containing Bis-
GMA. In the case of resazurin, this was statistically signiﬁcant
(p = 0.001). They also showed that Z250 extracts were less cyto-
compatible than all of the experimental formulations. MTS
showed no signiﬁcant differences between experimental for-
mulations but conﬁrmed the low cytocompatibility of Z250.
Metabolic activity in all assays varied from being similar to the
control for UP, down to ∼50% of control for Z250. Composites
containing TEGDMA caused a slight but signiﬁcant reduction
in resazurin activity compared to PPGDMA (p < 0.01), but WST-
8 and MTS assays showed no clear trends with regards to the
effect of diluent monomer.
After 72 h, similar trends were observed in all three assays,
with metabolic activity falling to approximately 50% of that
of the control for all experimental materials. The only dif-
ferences between assays were observed with Z250, where
resazurin activity had remained similar to the previous time-
point at ∼50%, but WST-8  activity had fallen from 53 to 37%
and MTS activity had fallen from 53 to 33%. These differences,
however, were not statistically signiﬁcant.
Resazurin and WST-8  suggested that 7-day extracts were
more  cytocompatible than 1 day extracts, since metabolic
activity returned to control levels after 72 h. The trend of the
48 h resazurin assay after 7 days extraction was similar to the
corresponding 1 day extract, but with slightly higher values.
For example, 48 h assays showed that BT – the least cytocom-
patible experimental composite – had 75% resazurin activity
relative to the control after 7 days extraction, compared to
56% after 1 day. In the case of all experimental formulations,
WST-8  activity was similar to the control or slightly elevated
by up to 11% after 48 h. The 7-day extract of Z250, however, still
caused a signiﬁcant reduction in WST-8  activity. After 72 h, the
resazurin and WST-8  activity of HGF exposed to 7-day extracts
had, in general, recovered. Resazurin activity of BT and Z250
remained slightly reduced at 89 and 82%, respectively. After
72 h, WST-8  activity of HGF exposed to all composite extracts
was elevated above that of the control by between 10 and
31%. The MTS assay gave signiﬁcantly different values com-
pared to the other two assays for the 7-day extracts. After
48 h, MTS  activity of HGF exposed to all experimental for-
mulations was 60–75% higher than the control and remained
similar after 72 h. Z250 values were similar to those reported
by WST-8. UDMA was also shown to be more  cytocompatible
than Bis-GMA in 7-day extracts (48 h resazurin assay, p = 0.03;
72 h WST-8  assay, p = 0.0008; 72 h MTS  assay, p = 0.007). WST-8
activity was also signiﬁcantly higher in cells exposed to 7-day
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Fig. 5 – Metabolic activity (relative to the corresponding control) of HGF after 48 (a and c) or 72 (b and d) h culture in 1 (a and
b) or 7 (c and d) day composite extracts, assessed by resazurin (dark gray), WST-8  (black) and MTS  (light gray) assays.
bars Dashed lines represent the mean value of the control, error 
extracts of PPGDMA-containing composites than TEGDMA-
containing composites after 48 h (p = 0.04).
4.  Discussion
As hypothesized, dental composites containing UDMA had
signiﬁcantly higher monomer conversion and slightly better
cytocompatibility than those containing Bis-GMA. Similarly,
composites containing PPGDMA achieved more  complete con-
version than those containing TEGDMA. Importantly, the use
of UDMA and/or PPGDMA as the sole bulk/diluent monomer
had no detrimental effect on the shrinkage or depth of cure of
the materials. In addition, composites containing UDMA had
improved handling properties compared to those containing
Bis-GMA.represent SD.
The variation in the conversion of the composites is
attributed to differences in the chemical structures (Fig. 6)
and physical characteristics (Table 2) of their constituent
monomers. Although UDMA is a slightly smaller molecule
than Bis-GMA and, as a result, has slightly higher double
bond concentration (ratio of double bonds per molecule to
molecular mass), its lower glass transition temperature (Tg)
and greater ﬂexibility enable more  complete cross-linking [15].
The bulky aromatic groups of Bis-GMA cause steric hindrance,
reﬂected in its very high viscosity value, which is ∼80 times
that of UDMA. This reduced ﬂexibility limits the likelihood of
methacrylate groups coming into contact with each other and
binding. PPGDMA has more  than twice the molecular mass of
TEGDMA and as a result, its greater ﬂexibility and lower double
bond concentration result in improved conversion.
The similar depth of cure of the composites is likely to be
due to the similar refractive indices of the monomers used
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Fig. 6 – Chemical structures of bulk monomers (a) UDMA and (b) Bis-GMA and diluent monomers (c) PPGDMA, where n ≈ 7
propylene glycol units and (d) TEGDMA.
Table 2 – Chemical and physical properties of bulk and diluent monomers. Data obtained from suppliers.
Monomer Molecular mass (Da) Density (g/cm3) Viscosity (Pa s) Refractive index Tg (◦C)
UDMA 470.6 1.129 ∼8.5 1.483 −35.3
Bis-GMA 512.6 1.161 ∼700 1.540 −7.7
PPGDMA 600.0 1.01 0.085 1.452 −62.0a
TEGDMA 286.3 1.09 0.050 1.461 −83.4
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aa Estimate based on poly(ethylene glycol-400) monomethyl ether mo
1.48 ± 0.04). The standard protocol, however, provides limited
nformation. The ‘scraping’ method described in BS EN ISO
049:2009 is a rough measure of composite hardness versus
epth, which likely suffers from variability between different
sers of the standard. In recognition of this, as well as the fact
hat the values obtained may not accurately reﬂect the depth
t which there is ≥50% conversion, the standard requires that
he value obtained is divided by 2. This appears to result in
nder-reporting of depth of cure values for some compos-
tes. A value of ≥50% monomer conversion may be considered
s indication that an average of one methacrylate group per
olecule has reacted and that the composite is cured and
ytocompatible [16]. This arises because the ﬁrst double bond
n dimethacrylates tends to polymerize faster than the sec-
nd. Using FTIR to assess the conversion at various speciﬁed
epths is advantageous and provides more  detailed informa-
ion than the standard depth of cure technique. With regards
o the present study, the ISO test predicts that all formulations
ave a similar depth of cure (2.7 ± 0.25 mm).  The measurement
f conversion at different depths, however, conﬁrms that UP,
T and BP have ≥50% at depths of at least 4 mm,  and that
T and Z250 are insufﬁciently cured at this depth. The use
f FTIR with ATR, a facile technique, therefore offers greater
nsight into the inter-related topics of monomer conversion
nd depth of cure.
FTIR can also be used to overcome the high margin of error
ssociated with the use of density determination apparatus
or assessment of shrinkage [17], which is highly sensitive
o entrapment of air bubbles and instability of balance read-
ngs. While the use of conversion values predicted that the
resent UDMA-containing composites would have slightly
igher shrinkage, the volume change method failed to elu-
idate clear differences between formulations. FTIR achieves
ower variability and requires fewer replicates, making it
dvantageous over BS EN ISO 17304:2013. It should, however,thacrylate.
be taken into account that Eq. (2) (S = (mC
∑
i
(nixi/wi) × 2250)
is based on the assumption that one mole of polymerizing
C C bonds typically undergoes volumetric shrinkage of ∼22.5
cm3 [8]. This generalized value for methacrylates is based on
results from Bis-GMA-based monomers and does not take into
account possible differences resulting from physical proper-
ties such as ﬂexibility or steric hindrance. The conversion
method gives more  reliable results and does not conﬂict with
those obtained by the volume change method.
Although high conversion is typically associated with
high shrinkage, composites containing UDMA had accept-
able shrinkage of 2.55–2.86 vol% (assessed by either method),
despite having slightly higher double bond concentration than
Bis-GMA and conversion as high as 62–67.5%. One possible
explanation for this may be that shrinkage of dimethacrylates
may be less strongly affected by the conversion of the second
double bond than the ﬁrst. Additionally, composites contain-
ing PPGDMA had, on average, slightly lower shrinkage than
those containing TEGDMA, despite having higher conversion.
This is due to PPGDMA having much lower double bond con-
centration, which results from its molecular mass being over
double that of TEGDMA.
A simpliﬁed version of BS EN ISO:2009 was used to esti-
mate water sorption from mass increase measurements after
one week storage in H2O, which allowed for the use of less
material. Bis-GMA induced slightly lower water sorption than
UDMA, due to the hydrophobicity of its aromatic groups.
Similarly, the propylene glycol groups of PPGDMA are more
hydrophobic than the ethylene glycol groups of TEGDMA.
Combined with the lower cross-linking density of TEGDMA,
this resulted in higher water sorption in TEGDMA-containing
composites.
The correlation between conversion and BFS of experi-
mental formulations is likely due to improved entrapment
of ﬁller particles in composites with greater cross-linking.
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Additionally, the interaction between the monomers and the
short, aliphatic silane (3-(trimethoxysilyl)propyl methacry-
late) coating on the ﬁllers, which has relatively low
hydrophobicity, is stronger with aliphatic groups (UDMA,
PPGDMA and TEGDMA) than aromatic groups (Bis-GMA). The
higher BFS of Z250 is likely due to differences in the ﬁllers
used, the composition of the liquid phase and the ﬁller to liq-
uid ratio. In the present paper, a molar ratio of bulk to diluent
monomer was used, in order to enable direct comparison of
conversion and cytocompatibility. The relatively low ratio of
diluent monomer used in this study is likely the reason that
Z250 had signiﬁcantly higher strength than BP and BT.
Although the densities of the monomers do not vary sig-
niﬁcantly, variations in molecular mass and viscosity result in
noticeable differences in composite handling properties. Bis-
GMA, in particular, is highly viscous and difﬁcult to handle,
due to its bulky aromatic rings. UDMA, despite its relatively
high viscosity, is signiﬁcantly less viscous than Bis-GMA, mak-
ing it more  facile to handle during clinical use and composite
manufacture. Although PPGDMA has higher viscosity than
TEGDMA, its molecular mass is more  than double that of
TEGDMA. This means that, when comparing composites with
the same molar ratio of bulk to diluent monomer (as opposed
to wt% ratio), handling properties were similar.
Despite the low solubility of most of the liquid phase com-
ponents analyzed in this study, it was possible to dissolve
them in cell culture medium at up to 10 mM (CQ and Bis-
GMA) or 100 mM (DMAEMA, PPGDMA, TEGDMA and UDMA).
Most components remained fully dispersed in the medium,
although CQ and TEGDMA did settle at high concentrations. In
order to ensure complete dispersal of the components, the test
solutions were thoroughly mixed by vortexing immediately
prior to adding them to each well.
Due to the limitations of cytocompatibility assays and vari-
ability between the different enzymatic substrates available
[5], the present study utilized three different assays (resazurin,
WST-8 and MTS) to assess the cytocompatibility of composite
liquid phase components and composite extracts. It is impor-
tant to take into consideration that the values obtained by
these assays report not the true cell density, as may be deter-
mined by cell counting. They are, instead, an estimate of cell
density based on the metabolic activity of the corresponding
enzyme. The nature of these assays relies on the assumption
that relative metabolic activity remains constant with time
after seeding. It can be seen in Fig. 3, however, that different
assays reported different cell densities over time in the con-
trols, despite having the same initial seeding density. For this
reason, the cytocompatibility of the composite components
and extracts was reported in terms of metabolic activity as a
percentage of the corresponding control, for each assay and
time-point. The use of serum-free medium did not noticeably
limit the proliferative potential of HGF over the short duration
of these assays (up to 48 h), since apparent cell density val-
ues fell within the expected range for HGF based on typical
culturing conditions with foetal bovine serum.
CQ was shown to have good cytocompatibility and, given
that it is present at low concentrations in the material, is
unlikely to cause a toxic effect. DMAEMA was demonstrated
to be highly cytotoxic. Unlike some other initiators, such
as N,N-dimethyl-p-toluidine, however, DMAEMA contains a2 ( 2 0 1 6 ) 264–277
methacrylate group which enables it to become incorporated
within the polymer and likely minimizes its release.
A wealth of studies have shown that dental monomers
such as Bis-GMA, UDMA and TEGDMA cause cytotoxic, geno-
toxic and apoptotic responses in a variety of cell types [18–22].
Presence of excessive reactive oxygen species have previ-
ously been shown to arrest cell cycle at different phases in
different ﬁbroblast types upon exposure to these monomers
[20,23–27]. As well as delaying cell cycle progression, these
monomers also impact on proliferation and survival and
cause inﬂammation and/or necrosis. TEGDMA has also been
shown to act as a vasorelaxant [28–32], to cause apopto-
sis and necrosis, which was associated with a reduction in
cdc2, cyclin B1 and cdc25C expression and increase in p21
expression [33] and upregulation of caspases [34]. Bis-GMA
induces inﬂammation and necrosis by upregulating expres-
sion of prostaglandin, tumour necrosis factor-a and various
surface antigens [35–37]. Although Bis-GMA is widely used
in dental composites, some researchers have concerns over
its ability to degrade to form bisphenol A [38]. Furthermore,
toxic monomers can be released by hydrolytic and enzymatic
degradation, as well as mechanical abrasion [22].
It was hypothesized that by increasing the length of the
diluent monomer by using PPGDMA instead of TEGDMA,
it would be possible to alleviate oxidative stress to some
degree [39]. In the present short-term study, HGF metabo-
lized resazurin signiﬁcantly more  efﬁciently after exposure to
PPGDMA, either in solution or via composite extracts, than
after exposure to TEGDMA or UDMA. HGF failed, however, to
efﬁciently metabolize WST-8  and MTS after exposure to any
of these components, even at low concentrations.
Bis-GMA had a lesser effect on metabolic activity of HGF
than the other monomers, up to a concentration of at least
0.1 mM.  Its TC50 value (the concentration at which 50% of
cells survived) was in the range of ∼0.5–1 mM,  consistent
with previous ﬁndings in HGF and HaCaT (keratinocyte cell
line) [40] and an order of magnitude higher than observed
in some other cell lines (e.g. L929) [41,42]. This highlights
the potential for variability, which can arise between differ-
ent cell types and methods of material preparation, culture
duration, seeding density, etc. Although neither the longer-
term cytotoxic effects nor the genotoxic effects of Bis-GMA
were investigated, previous studies have demonstrated that
the use of Bis-GMA in dental materials is cause for concern.
The use of alternative monomers with excellent mechanical
properties and relatively high viscosity, but lower viscosity
and with better handling properties than Bis-GMA, would
therefore be ideal. The TC50 of UDMA and TEGDMA could
not be directly compared to previous ﬁndings, since even at
the lowest concentration tested, fewer than 50% of cells were
viable after 48 h. The TC50 values of UDMA (≤0.01 mM)  and
TEGDMA (<0.01 mM)  were notably lower, however, than previ-
ously observed (∼0.06–4 mM [24,40,42] and ∼1–4.1 mM [40,42],
respectively).
UDMA is also widely used in dental composites, typically
in combination with Bis-GMA and/or similar high viscosity
monomers. The use of UDMA has been shown to result in
signiﬁcantly higher conversion, more  complete cross-linking
and lower leaching of uncured monomer than Bis-GMA [4],
as well as higher ﬂexural strength and hardness [43]. It has
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herefore been suggested that UDMA may be used as the
ole bulk monomer in orthodontic adhesives [3] and bone
ements [44]. In the present study, the use of UDMA as the
ole bulk monomer in a dental composite was investigated.
t was hypothesized that its higher conversion would result
n improved cytocompatibility due to reduced leaching of un-
ross-linked monomers and initiators (such as the highly toxic
MAEMA). Despite UDMA being more  cytotoxic to HGF than
is-GMA in solution, the results of the 48 h resazurin and
ST-8 assays suggest that 1 day extracts of UDMA-containing
omposites were more  cytocompatible than those of Bis-GMA-
ontaining composites. After a subsequent recovery period,
owever, all three assays showed similar metabolic activity
fter exposure to all materials, suggesting that UDMA is sim-
larly cytotoxic but has a delayed action. These ﬁndings may
esult from a combination of the greater presence of Bis-GMA
nd diluent monomers in the extracts, due to Bis-GMA’s poorer
onversion, and UDMA’s higher cytotoxicity.
Although water-soluble assays offer a convenient insight
nto the cytocompatibility of biomaterials, they have the draw-
ack of being unable to differentiate between cells that are
ctively proliferating and cells that are in a quiescent state [45].
his is reﬂected in the over-estimation of cell density by the
TS  assay in the present study. Overestimation and/or under-
stimation can also result from interference caused by the
ompound being analyzed. Although resazurin [46], WST-8  [47]
nd MTS  [48] have all been previously reported to overestimate
nd/or underestimate cell number, MTS  appears to be particu-
arly affected. In the present study, the MTS  assay’s signiﬁcant
nderestimation of cell density in the control was most likely
he cause of its overestimation of metabolic activity per cell.
Further complications arise from the fact that different
tudies utilize varying cell types. Given their differing pheno-
ypes and susceptibility to cytotoxic and genotoxic effects [49],
irect comparisons cannot be made. In addition, short-term
ytocompatibility studies do not take into account possible
enotoxic and mutagenic effects. Although it was beyond the
cope of this study, future research into the longer-term cyto-
oxic and genotoxic effects of a wide range of commonly used
omposite components would be highly beneﬁcial in elucidat-
ng the causes of the complex trends observed in this and other
tudies. Although an extensive range of such studies has been
erformed, the different parameters investigated between
ifferent research groups (material concentration, material
reparation, extraction technique, cell type, assay, genes ana-
yzed, duration of study) make it difﬁcult to directly compare
esults and deﬁnitively interpret them. Better understanding
f the fundamental effects of each individual component is
equired in order to improve the biocompatibility of novel den-
al composites. A more  systematic and wide-ranging approach
ould be beneﬁcial in establishing a library which comprehen-
ively documents the effects of each component.
More  comprehensive studies are therefore required to elu-
idate the longer-term effects of monomers and composite
xtracts on a wide range of markers of biocompatibility in
 variety of relevant cell types. This includes analysis of
xpression of cell surface markers and genes implicated in
xidative stress and apoptotic response, in parallel with mul-
iple metabolic activity assays and quantiﬁcation of total
NA. This would enable more  targeted design of novel( 2 0 1 6 ) 264–277 275
composites with improved biocompatibility for improved
treatment of dental caries.
5.  Conclusions
It can be concluded that UDMA signiﬁcantly improved con-
version, BFS and depth of cure compared to Bis-GMA, due
to its greater ﬂexibility and lower Tg. Its higher conversion
also slightly improved cytocompatibility, likely due to reduced
monomers leaching. PPGDMA improved conversion relative to
TEGDMA. The use of UDMA and PPGDMA did not cause a detri-
mental increase in polymerization shrinkage. Although the
resazurin assay suggested that PPGDMA be more  cytocompati-
ble than TEGDMA, WST-8  and MTS  assays proved inconclusive.
Longer-term cytocompatibility and genocompatibility testing
is therefore required.
Furthermore, MTS signiﬁcantly over-estimated metabolic
activity. Additionally, FTIR is a facile technique which provides
greater information about the depth of cure of composites and
appears to accurately predict polymerization shrinkage.
These results suggest that careful consideration should be
given to the polymerization behaviour of the monomers used
in dental composites, as well as their cytocompatibility. This
is particularly true in the case of bulk ﬁll materials, which
aim to expedite the treatment of carious lesions by reducing
the number of composite layers required, since the effect of
monomer on conversion of the present composites was more
pronounced at 4 mm than at 1 mm.  Furthermore, the cyto-
compatibility test, which demonstrated that all formulations
affect metabolic activity to different degrees, utilized speci-
mens from the bottom 1 mm from a 4 mm stack. The deepest
section of a restoration receives the lowest intensity of light
during curing and as a result, can suffer from poor conver-
sion if the constituent monomers lack ﬂexibility. Given that
this is also the most likely region of the composite to be in
close proximity to pulp tissue, cytocompatibility is of particu-
lar importance for bulk ﬁll materials.
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